Philadelphia Trust CO Sigilon Therapeutics, Inc. Transaction History

Philadelphia Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.42 - $10.61 $198,900 - $477,450	-45,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$9.15 - $20.17 $328,594 - $724,345	-35,912 Reduced 44.38%	45,000 $483,000
Q1 2021 May 14, 2021	BUY	$18.76 - $40.91 $1.26 Million - $2.75 Million	67,268 Added 493.02%	80,912 $1.81 Million
Q4 2020 Feb 08, 2021	BUY	$27.6 - $48.03 $376,574 - $655,321	13,644 New	13,644 $655,000

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

Stay updated on Philadelphia Trust CO with notifications on news.